McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone972-446-4800
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$214.32 billion
Profitability
Miscellaneous
Employees80,000
Next Earnings Date7/25/2019 (Estimated)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson declared a quarterly dividend on Thursday, April 25th. Investors of record on Monday, June 3rd will be paid a dividend of $0.39 per share on Monday, July 1st. This represents a $1.56 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date is Friday, May 31st. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) issued its quarterly earnings data on Wednesday, May, 8th. The company reported $3.69 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.66 by $0.03. The firm had revenue of $52.43 billion for the quarter, compared to analysts' expectations of $53.14 billion. McKesson had a return on equity of 29.02% and a net margin of 0.02%. The company's revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.49 earnings per share. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY20 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of $13.85-14.45 for the period, compared to the Thomson Reuters consensus estimate of $14.09.
What price target have analysts set for MCK?
13 brokers have issued twelve-month target prices for McKesson's stock. Their forecasts range from $2.86 to $175.00. On average, they expect McKesson's share price to reach $133.9860 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Media stories about MCK stock have trended positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. McKesson earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
- Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)
Who are McKesson's major shareholders?
McKesson's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.71%), Wellington Management Group LLP (4.11%), FMR LLC (2.66%), Boston Partners (2.48%), Vulcan Value Partners LLC (2.20%) and Pzena Investment Management LLC (1.92%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which major investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, BlackRock Inc., Renaissance Technologies LLC, Boston Partners, AQR Capital Management LLC, Vulcan Value Partners LLC, State Treasurer State of Michigan and Goldman Sachs Group Inc.. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, Lori A Schechter and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which major investors are buying McKesson stock?
MCK stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Pzena Investment Management LLC, Ruffer LLP, BNP Paribas Arbitrage SA, Jacobs Levy Equity Management Inc., Skandinaviska Enskilda Banken AB publ , Dimensional Fund Advisors LP and LSV Asset Management. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $129.09.
How big of a company is McKesson?
McKesson has a market capitalization of $24.52 billion and generates $214.32 billion in revenue each year. The company earns $34 million in net income (profit) each year or $13.57 on an earnings per share basis. McKesson employs 80,000 workers across the globe.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
